🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the efficacy and safety of venetocl...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2023-03-01
Trial ID
NCT06068621
RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Status
Completed
Location
AZ Sint-Jan
Start Date
2003-11
Trial ID
NCT00077116
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Algemeen Ziekenhuis Middelheim
Start Date
1993-03
Trial ID
NCT00002517
Advances in the biological characterization of AML can now make a proper es...
Status
Unknown
Location
Hospital La Fe
Start Date
2010-12
Trial ID
NCT01296178
Treatments Being Tested
In this study, newly diagnosed non-elderly patients with Philadelphia chrom...
Status
Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2024-02-05
Trial ID
NCT06250959
Treatments Being Tested
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
Older patients with acute myeloid leukemia (AML) have a small (\< 10%) chan...
Status
Unknown
Location
UZ Antwerpen
Start Date
2014-11-28
Trial ID
NCT02172872
Treatments Being Tested
This phase IB trial studies the feasibility of using a functional laborator...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2016-01-13
Trial ID
NCT02779283
Treatments Being Tested
Ph-like ALL is a recently recognized high-risk subgroup and the optimal the...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564470
The study will include newly-diagnosed AML patients, not suffering acute pr...
Status
Unknown
Location
Weill Cornell Medicine
Start Date
2017-07-03
Trial ID
NCT03257241
Treatments Being Tested